Predictive Modeling of In Vivo Response to Gemcitabine in Pancreatic Cancer

A clear contradiction exists between cytotoxic in-vitro studies demonstrating effectiveness of Gemcitabine to curtail pancreatic cancer and in-vivo studies failing to show Gemcitabine as an effective treatment. The outcome of chemotherapy in metastatic stages, where surgery is no longer viable, show...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, James J., Huang, Justin, England, Christopher G., McNally, Lacey R., Frieboes, Hermann B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777914/
https://www.ncbi.nlm.nih.gov/pubmed/24068909
http://dx.doi.org/10.1371/journal.pcbi.1003231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777914/
https://www.ncbi.nlm.nih.gov/pubmed/24068909
http://dx.doi.org/10.1371/journal.pcbi.1003231

Ejemplares similares